New studies confirm that multiple types of steroids improve survival for severely ill COVID-19 patients, cementing the cheap drugs as a standard of care.
An analysis of pooled results from seven studies, led by the World Health Organization and published today by the Journal of the American Medical Association, found that steroids reduce the risk of death in the first month by about one-third compared to placebo treatment or usual care alone in these seriously ill patients who need extra oxygen.
“This result opens up more choices” of steroids, says Dr. Martin Landray of the University of Oxford, who led one of the studies. “The more options there are in terms of availability, the better.”
Illustrative: A bottle and box for the steroid dexamethasone (AP Photo/Nati Harnik)
Dr. Anthony Gordon of Imperial College London calls the result “a huge step forward,” but adds, “as impressive as these results are, it’s not a cure.”
Steroid drugs are inexpensive, widely available and have been used for decades. They reduce inflammation, which sometimes develops in coronavirus patients as the immune system overreacts to fight the infection. This overreaction damages the lungs and can prove fatal. These drugs are not the same type of steroids that are used or misused for athletic performance.
— AP
Animal lovers, this one's for you
In 1935, Rabbi Max Shorenstein left Denmark to pursue his lifelong dream: building a zoo in Tel Aviv and teaching children to love animals. The Tel Aviv Zoo became one of the city’s greatest attractions, but envy, greed, and corruption drove Shorenstein from the paradise he created.
The film 'There Are No Lions in Tel Aviv' is available to screen November 19-26 for members of our reader support group, The Times of Israel Community. Join the Community todayto support our work and watch our DocuNation series of outstanding Israeli documentary films.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel